Childhood-onset systemic lupus erythematosus (cSLE) and malignancy: a nationwide multicentre series review

Autor: Matheus Zanata Brufatto, Sean Hideo Shirata Lanças, Taciana de Albuquerque Pedrosa Fernandes, Adriana Maluf Elias Sallum, Lucia Maria Arruda Campos, Ana Paula Sakamoto, Maria Teresa Terreri, Flavio Roberto Sztajnbok, Blanca Elena Rios Gomes Bica, Virginia Paes Leme Ferriani, Luciana Martins de Carvalho, Clovis Artur Almeida Silva, Claudia Saad-Magalhaes

Publikováno v: Advances in Rheumatology, Vol 64, Iss 1, Pp 1-7 (2024)

Abstract Background Increased malignancy frequency is well documented in adult-systemic lupus erythematosus (SLE), but with limited reports in childhood-onset SLE (cSLE) series. We explored the frequency of malignancy associated with cSLE, describing

Externí odkaz: https://doaj.org/article/8a85221b8c154d9194ce11de7bfb0555

TESTING ANTINUCLEAR ANTIBODIES IN RELATIVES OF PATIENTS WITH SYSTEMIC LUPUS ERITHEMATOSUS

Autor: Madalina-Pusa Duna, Denisa Predeteanu, F. Berghea, Daniela Opris-Belinski, Ruxandra Ionescu

Publikováno v: Romanian Journal of Rheumatology, Vol 27, Iss 4, Pp 164-168 (2018)

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies, which deposit within tissues and fix complement leading to systemic inflammation (1). Is a heterogeneous disease with a continuum of

Externí odkaz: https://doaj.org/article/0c93c93fa1e644b9be821d5dd3fc805d

Avaliação dos óbitos e necropsias em pacientes internados em um serviço de reumatologia pediátrica por um período de dez anos Deaths and necropsies evaluation in hospitalized patients of a pediatric rheumatology unit for a period of ten years

Autor: Mércia Moreira Facó, Lucia Akemi Nukumizu, Ana Júlia Pantoja de Moraes, Paula Cruz Borreli Barros, Eduardo Juan Troster, Clovis Artur Almeida da Silva

Publikováno v: Revista Brasileira de Reumatologia, Vol 45, Iss 2, Pp 55-63 (2005)

OBJETIVO: correlacionar os dados clínicos do óbito com achados de necropsia em pacientes internados em uma unidade de reumatologia pediátrica. MÉTODOS: o estudo é uma coorte histórica. Em dez anos, no período compreendido entre janeiro de 1994

Externí odkaz: https://doaj.org/article/ad012754308c4daebf87e1b94f14339e

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus

Autor: Juan Carlos Quevedo-Abeledo, Laura de Armas-Rillo, Hiurma Sánchez-Pérez, Miguel A. González-Gay, Iván Ferraz-Amaro, Beatriz Tejera-Segura, Iñigo Rúa-Figueroa

Publikováno v: Therapeutic advances in neurological disorders 2020, Vol. 12: 1-14
UCrea Repositorio Abierto de la Universidad de Cantabria
instname
Therapeutic Advances in Musculoskeletal Disease, Vol 12 (2020)
Therapeutic Advances in Musculoskeletal Disease

Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a serine protease that regulates cholesterol metabolism through low-density lipoprotein receptor degradation and that has been linked to cardiovascular (CV) disease. The purpose of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e79d0ac25ab054b204857b2a248677e
http://hdl.handle.net/10902/21168

Clinical significance of rare serum autoantibodies in rheumatic diseases: a systematic literature review

Autor: Natasa Isailovic, Carlo Selmi, Angela Ceribelli, Bianca Palermo, Carolina Gorlino, Maria De Santis, Elena Generali

Publikováno v: CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET

The identification of serum autoantibodies is central in the diagnosis of systemic autoimmune rheumatic disease (SARD), and an increasing number of specificities have been detected in the past years. This allows an early diagnosis in the active phase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eef7fe066ef96efb65b7ad5c9beafef
http://jlpm.amegroups.com/article/view/4579/5636